PD-1 and PD-L1 Drug - Global and China Top Players Market Share and Ranking 2023
According to Latest Study, the global market for PD-1 and PD-L1 Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China PD-1 and PD-L1 Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States PD-1 and PD-L1 Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Liver Cancer grew percent to account for percent of the total market sales, and Esophageal Cancer grew percent.
PD-1/PD-L1 is an important part of the human immune system-a drug target on T cells. Drugs designed for this target can activate the immune effect of T cells on tumor cells, thereby awakening the patient's own anti-cancer effect. tumor effect.
This report studies and analyses global PD-1 and PD-L1 Drug status and future trends, helps the client to determine the PD-1 and PD-L1 Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for PD-1 and PD-L1 Drug, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global PD-1 and PD-L1 Drug market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global PD-1 and PD-L1 Drug sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China PD-1 and PD-L1 Drug sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global PD-1 and PD-L1 Drug key consuming regions, consumption quantity, consumption value and demand structure
(5) Global PD-1 and PD-L1 Drug key producing regions, capacity, production, and year over year growth
(6) PD-1 and PD-L1 Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Bristol Myers Squibb
Merck & Co., Inc.
F. Hoffmann -La Roche Ltd
AstraZeneca
Sanofi
Pfizer Inc
Lilly
Novartis AG
GSK
Junshi Biosciences
Akeso, Inc
BeiGene
Innovent
Jiangsu Hengrui Medicine Co.,Ltd
Cstone
Henlius
Simcere Pharmaceutical Group Limited
Market segment by Type, covers
PD-1 Monoclonal Antibody
PD-L1 Monoclonal Antibody
Market segment by Application, can be divided into
Liver Cancer
Esophageal Cancer
Nasal Cancer
Stomach Cancer
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe PD-1 and PD-L1 Drug product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global PD-1 and PD-L1 Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China PD-1 and PD-L1 Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of PD-1 and PD-L1 Drug, percent & CAGR, 2018-2029
Chapter 5: PD-1 and PD-L1 Drug industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 PD-1 and PD-L1 Drug Definition
1.2 Global PD-1 and PD-L1 Drug Market Size and Forecast
1.2.1 By Consumption Value, Global PD-1 and PD-L1 Drug Market Size，2018-2029
1.2.2 By Sales Quantity, Global PD-1 and PD-L1 Drug Market Size，2018-2029
1.2.3 Global PD-1 and PD-L1 Drug Average Selling Price (ASP)，2018-2029
1.3 China PD-1 and PD-L1 Drug Market Size and Forecast
1.3.1 By Consumption Value, China PD-1 and PD-L1 Drug Market Size，2018-2029
1.3.2 By Sales Quantity, China PD-1 and PD-L1 Drug Market Size，2018-2029
1.3.3 China PD-1 and PD-L1 Drug Average Selling Price (ASP)， 2018-2029
1.4 Share of China PD-1 and PD-L1 Drug Market with Respect to the Global Market
1.4.1 By Consumption Value, China PD-1 and PD-L1 Drug Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China PD-1 and PD-L1 Drug Market Share in Global, 2018-2029
1.4.3 PD-1 and PD-L1 Drug Market Size: China VS Global, 2018-2029
1.5 PD-1 and PD-L1 Drug Market Dynamics
1.5.1 PD-1 and PD-L1 Drug Market Drivers
1.5.2 PD-1 and PD-L1 Drug Market Restraints
1.5.3 PD-1 and PD-L1 Drug Industry Trends
1.5.4 PD-1 and PD-L1 Drug Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of PD-1 and PD-L1 Drug, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of PD-1 and PD-L1 Drug, Global Market Share by Company, 2018-2023
2.3 PD-1 and PD-L1 Drug Average Selling Price (ASP) by Company, 2018-2023
2.4 Global PD-1 and PD-L1 Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global PD-1 and PD-L1 Drug Concentration Ratio
2.6 Global PD-1 and PD-L1 Drug Mergers & Acquisitions, Expansion Plans
2.7 Global PD-1 and PD-L1 Drug Manufacturers Product Type
2.8 Head Office and PD-1 and PD-L1 Drug Production Site of Key Manufacturer
2.9 PD-1 and PD-L1 Drug Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of PD-1 and PD-L1 Drug, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of PD-1 and PD-L1 Drug, China Market Share by Company, 2018-2023
3.3 China PD-1 and PD-L1 Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global PD-1 and PD-L1 Drug Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global PD-1 and PD-L1 Drug Capacity by Region
4.3 Global PD-1 and PD-L1 Drug Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global PD-1 and PD-L1 Drug Production by Region, 2018-2029
4.5 Global PD-1 and PD-L1 Drug Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 PD-1 and PD-L1 Drug Industry Chain
5.2 PD-1 and PD-L1 Drug Upstream Analysis
5.2.1 PD-1 and PD-L1 Drug Core Raw Materials
5.2.2 Main Manufacturers of PD-1 and PD-L1 Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 PD-1 and PD-L1 Drug Production Mode
5.6 PD-1 and PD-L1 Drug Procurement Model
5.7 PD-1 and PD-L1 Drug Industry Sales Model and Sales Channels
5.7.1 PD-1 and PD-L1 Drug Sales Model
5.7.2 PD-1 and PD-L1 Drug Typical Distributors
6 Sights by Type
6.1 PD-1 and PD-L1 Drug Classification
6.1.1 PD-1 Monoclonal Antibody
6.1.2 PD-L1 Monoclonal Antibody
6.2 By Type, Global PD-1 and PD-L1 Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029
6.4 By Type, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029
6.5 By Type, Global PD-1 and PD-L1 Drug Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 PD-1 and PD-L1 Drug Segment by Application
7.1.1 Liver Cancer
7.1.2 Esophageal Cancer
7.1.3 Nasal Cancer
7.1.4 Stomach Cancer
7.1.5 Other
7.2 By Application, Global PD-1 and PD-L1 Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029
7.4 By Application, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029
7.5 By Application, Global PD-1 and PD-L1 Drug Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global PD-1 and PD-L1 Drug Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029
8.3 By Region, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America PD-1 and PD-L1 Drug & Forecasts, 2018-2029
8.4.2 By Country, North America PD-1 and PD-L1 Drug Market Size Market Share
8.5 Europe
8.5.1 Europe PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe PD-1 and PD-L1 Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific PD-1 and PD-L1 Drug Market Size Market Share
8.7 South America
8.7.1 South America PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America PD-1 and PD-L1 Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global PD-1 and PD-L1 Drug Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029
9.3 By Country, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. PD-1 and PD-L1 Drug Market Size, 2018-2029
9.4.2 By Type, U.S. PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe PD-1 and PD-L1 Drug Market Size, 2018-2029
9.5.2 By Type, Europe PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China PD-1 and PD-L1 Drug Market Size, 2018-2029
9.6.2 By Type, China PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan PD-1 and PD-L1 Drug Market Size, 2018-2029
9.7.2 By Type, Japan PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea PD-1 and PD-L1 Drug Market Size, 2018-2029
9.8.2 By Type, South Korea PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia PD-1 and PD-L1 Drug Market Size, 2018-2029
9.9.2 By Type, Southeast Asia PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India PD-1 and PD-L1 Drug Market Size, 2018-2029
9.10.2 By Type, India PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa PD-1 and PD-L1 Drug Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Bristol Myers Squibb
10.1.1 Bristol Myers Squibb Company Information, Head Office, Market Area, and Industry Position
10.1.2 Bristol Myers Squibb PD-1 and PD-L1 Drug Models, Specifications, and Application
10.1.3 Bristol Myers Squibb PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Bristol Myers Squibb Company Profile and Main Business
10.1.5 Bristol Myers Squibb Recent Developments
10.2 Merck & Co., Inc.
10.2.1 Merck & Co., Inc. Company Information, Head Office, Market Area, and Industry Position
10.2.2 Merck & Co., Inc. PD-1 and PD-L1 Drug Models, Specifications, and Application
10.2.3 Merck & Co., Inc. PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Merck & Co., Inc. Company Profile and Main Business
10.2.5 Merck & Co., Inc. Recent Developments
10.3 F. Hoffmann -La Roche Ltd
10.3.1 F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area, and Industry Position
10.3.2 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Models, Specifications, and Application
10.3.3 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 F. Hoffmann -La Roche Ltd Company Profile and Main Business
10.3.5 F. Hoffmann -La Roche Ltd Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.4.2 AstraZeneca PD-1 and PD-L1 Drug Models, Specifications, and Application
10.4.3 AstraZeneca PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 AstraZeneca Company Profile and Main Business
10.4.5 AstraZeneca Recent Developments
10.5 Sanofi
10.5.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.5.2 Sanofi PD-1 and PD-L1 Drug Models, Specifications, and Application
10.5.3 Sanofi PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Sanofi Company Profile and Main Business
10.5.5 Sanofi Recent Developments
10.6 Pfizer Inc
10.6.1 Pfizer Inc Company Information, Head Office, Market Area, and Industry Position
10.6.2 Pfizer Inc PD-1 and PD-L1 Drug Models, Specifications, and Application
10.6.3 Pfizer Inc PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Pfizer Inc Company Profile and Main Business
10.6.5 Pfizer Inc Recent Developments
10.7 Lilly
10.7.1 Lilly Company Information, Head Office, Market Area, and Industry Position
10.7.2 Lilly PD-1 and PD-L1 Drug Models, Specifications, and Application
10.7.3 Lilly PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Lilly Company Profile and Main Business
10.7.5 Lilly Recent Developments
10.8 Novartis AG
10.8.1 Novartis AG Company Information, Head Office, Market Area, and Industry Position
10.8.2 Novartis AG PD-1 and PD-L1 Drug Models, Specifications, and Application
10.8.3 Novartis AG PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Novartis AG Company Profile and Main Business
10.8.5 Novartis AG Recent Developments
10.9 GSK
10.9.1 GSK Company Information, Head Office, Market Area, and Industry Position
10.9.2 GSK PD-1 and PD-L1 Drug Models, Specifications, and Application
10.9.3 GSK PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 GSK Company Profile and Main Business
10.9.5 GSK Recent Developments
10.10 Junshi Biosciences
10.10.1 Junshi Biosciences Company Information, Head Office, Market Area, and Industry Position
10.10.2 Junshi Biosciences PD-1 and PD-L1 Drug Models, Specifications, and Application
10.10.3 Junshi Biosciences PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Junshi Biosciences Company Profile and Main Business
10.10.5 Junshi Biosciences Recent Developments
10.11 Akeso, Inc
10.11.1 Akeso, Inc Company Information, Head Office, Market Area, and Industry Position
10.11.2 Akeso, Inc PD-1 and PD-L1 Drug Models, Specifications, and Application
10.11.3 Akeso, Inc PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Akeso, Inc Company Profile and Main Business
10.11.5 Akeso, Inc Recent Developments
10.12 BeiGene
10.12.1 BeiGene Company Information, Head Office, Market Area, and Industry Position
10.12.2 BeiGene PD-1 and PD-L1 Drug Models, Specifications, and Application
10.12.3 BeiGene PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 BeiGene Company Profile and Main Business
10.12.5 BeiGene Recent Developments
10.13 Innovent
10.13.1 Innovent Company Information, Head Office, Market Area, and Industry Position
10.13.2 Innovent PD-1 and PD-L1 Drug Models, Specifications, and Application
10.13.3 Innovent PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Innovent Company Profile and Main Business
10.13.5 Innovent Recent Developments
10.14 Jiangsu Hengrui Medicine Co.,Ltd
10.14.1 Jiangsu Hengrui Medicine Co.,Ltd Company Information, Head Office, Market Area, and Industry Position
10.14.2 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Models, Specifications, and Application
10.14.3 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Jiangsu Hengrui Medicine Co.,Ltd Company Profile and Main Business
10.14.5 Jiangsu Hengrui Medicine Co.,Ltd Recent Developments
10.15 Cstone
10.15.1 Cstone Company Information, Head Office, Market Area, and Industry Position
10.15.2 Cstone PD-1 and PD-L1 Drug Models, Specifications, and Application
10.15.3 Cstone PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Cstone Company Profile and Main Business
10.15.5 Cstone Recent Developments
10.16 Henlius
10.16.1 Henlius Company Information, Head Office, Market Area, and Industry Position
10.16.2 Henlius PD-1 and PD-L1 Drug Models, Specifications, and Application
10.16.3 Henlius PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Henlius Company Profile and Main Business
10.16.5 Henlius Recent Developments
10.17 Simcere Pharmaceutical Group Limited
10.17.1 Simcere Pharmaceutical Group Limited Company Information, Head Office, Market Area, and Industry Position
10.17.2 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Models, Specifications, and Application
10.17.3 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Simcere Pharmaceutical Group Limited Company Profile and Main Business
10.17.5 Simcere Pharmaceutical Group Limited Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. PD-1 and PD-L1 Drug Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. PD-1 and PD-L1 Drug Market Restraints
Table 3. PD-1 and PD-L1 Drug Market Trends
Table 4. PD-1 and PD-L1 Drug Industry Policy
Table 5. Global PD-1 and PD-L1 Drug Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global PD-1 and PD-L1 Drug Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global PD-1 and PD-L1 Drug Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global PD-1 and PD-L1 Drug Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global PD-1 and PD-L1 Drug Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global PD-1 and PD-L1 Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global PD-1 and PD-L1 Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global PD-1 and PD-L1 Drug Manufacturers Product Type
Table 13. Head Office and PD-1 and PD-L1 Drug Production Site of Key Manufacturer
Table 14. PD-1 and PD-L1 Drug Capacity of Major Manufacturers and Future Plan
Table 15. China PD-1 and PD-L1 Drug Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China PD-1 and PD-L1 Drug Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China PD-1 and PD-L1 Drug Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global PD-1 and PD-L1 Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global PD-1 and PD-L1 Drug Production by Region, 2018-2023, (K Units)
Table 20. Global PD-1 and PD-L1 Drug Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of PD-1 and PD-L1 Drug Upstream (Raw Materials)
Table 22. Global PD-1 and PD-L1 Drug Typical Customers
Table 23. PD-1 and PD-L1 Drug Typical Distributors
Table 24. By Type, Global PD-1 and PD-L1 Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global PD-1 and PD-L1 Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global PD-1 and PD-L1 Drug Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global PD-1 and PD-L1 Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global PD-1 and PD-L1 Drug Consumption Value Market Share, 2018-2029
Table 32. By Country, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global PD-1 and PD-L1 Drug Sales Quantity Market Share, 2018-2029
Table 34. Bristol Myers Squibb Company Information, Head Office, Market Area, and Industry Position
Table 35. Bristol Myers Squibb PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 36. Bristol Myers Squibb PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Bristol Myers Squibb Company Profile and Main Business
Table 38. Bristol Myers Squibb Recent Developments
Table 39. Merck & Co., Inc. Company Information, Head Office, Market Area, and Industry Position
Table 40. Merck & Co., Inc. PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 41. Merck & Co., Inc. PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Merck & Co., Inc. Company Profile and Main Business
Table 43. Merck & Co., Inc. Recent Developments
Table 44. F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area, and Industry Position
Table 45. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 46. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. F. Hoffmann -La Roche Ltd Company Profile and Main Business
Table 48. F. Hoffmann -La Roche Ltd Recent Developments
Table 49. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 50. AstraZeneca PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 51. AstraZeneca PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. AstraZeneca Company Profile and Main Business
Table 53. AstraZeneca Recent Developments
Table 54. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 55. Sanofi PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 56. Sanofi PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Sanofi Company Profile and Main Business
Table 58. Sanofi Recent Developments
Table 59. Pfizer Inc Company Information, Head Office, Market Area, and Industry Position
Table 60. Pfizer Inc PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 61. Pfizer Inc PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Pfizer Inc Company Profile and Main Business
Table 63. Pfizer Inc Recent Developments
Table 64. Lilly Company Information, Head Office, Market Area, and Industry Position
Table 65. Lilly PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 66. Lilly PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Lilly Company Profile and Main Business
Table 68. Lilly Recent Developments
Table 69. Novartis AG Company Information, Head Office, Market Area, and Industry Position
Table 70. Novartis AG PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 71. Novartis AG PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Novartis AG Company Profile and Main Business
Table 73. Novartis AG Recent Developments
Table 74. GSK Company Information, Head Office, Market Area, and Industry Position
Table 75. GSK PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 76. GSK PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. GSK Company Profile and Main Business
Table 78. GSK Recent Developments
Table 79. Junshi Biosciences Company Information, Head Office, Market Area, and Industry Position
Table 80. Junshi Biosciences PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 81. Junshi Biosciences PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Junshi Biosciences Company Profile and Main Business
Table 83. Junshi Biosciences Recent Developments
Table 84. Akeso, Inc Company Information, Head Office, Market Area, and Industry Position
Table 85. Akeso, Inc PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 86. Akeso, Inc PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Akeso, Inc Company Profile and Main Business
Table 88. Akeso, Inc Recent Developments
Table 89. BeiGene Company Information, Head Office, Market Area, and Industry Position
Table 90. BeiGene PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 91. BeiGene PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. BeiGene Company Profile and Main Business
Table 93. BeiGene Recent Developments
Table 94. Innovent Company Information, Head Office, Market Area, and Industry Position
Table 95. Innovent PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 96. Innovent PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Innovent Company Profile and Main Business
Table 98. Innovent Recent Developments
Table 99. Jiangsu Hengrui Medicine Co.,Ltd Company Information, Head Office, Market Area, and Industry Position
Table 100. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 101. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Jiangsu Hengrui Medicine Co.,Ltd Company Profile and Main Business
Table 103. Jiangsu Hengrui Medicine Co.,Ltd Recent Developments
Table 104. Cstone Company Information, Head Office, Market Area, and Industry Position
Table 105. Cstone PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 106. Cstone PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Cstone Company Profile and Main Business
Table 108. Cstone Recent Developments
Table 109. Henlius Company Information, Head Office, Market Area, and Industry Position
Table 110. Henlius PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 111. Henlius PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Henlius Company Profile and Main Business
Table 113. Henlius Recent Developments
Table 114. Simcere Pharmaceutical Group Limited Company Information, Head Office, Market Area, and Industry Position
Table 115. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Models, Specifications, and Application
Table 116. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Simcere Pharmaceutical Group Limited Company Profile and Main Business
Table 118. Simcere Pharmaceutical Group Limited Recent Developments
List of Figures
Figure 1. PD-1 and PD-L1 Drug Picture
Figure 2. Global PD-1 and PD-L1 Drug Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global PD-1 and PD-L1 Drug Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global PD-1 and PD-L1 Drug Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China PD-1 and PD-L1 Drug Consumption Value, (US$ million) & (2018-2029)
Figure 6. China PD-1 and PD-L1 Drug Sales Quantity (K Units) & (2018-2029)
Figure 7. China PD-1 and PD-L1 Drug Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China PD-1 and PD-L1 Drug Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China PD-1 and PD-L1 Drug Market Share of Global, 2018-2029
Figure 10. Global PD-1 and PD-L1 Drug Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China PD-1 and PD-L1 Drug Key Participants, Market Share, 2022
Figure 12. Global PD-1 and PD-L1 Drug Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global PD-1 and PD-L1 Drug Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global PD-1 and PD-L1 Drug Production Market Share & Forecast by Region, 2018-2029
Figure 15. PD-1 and PD-L1 Drug Industry Chain
Figure 16. PD-1 and PD-L1 Drug Procurement Model
Figure 17. PD-1 and PD-L1 Drug Sales Model
Figure 18. PD-1 and PD-L1 Drug Sales Channels, Direct Sales, and Distribution
Figure 19. PD-1 Monoclonal Antibody
Figure 20. PD-L1 Monoclonal Antibody
Figure 21. By Type, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global PD-1 and PD-L1 Drug Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global PD-1 and PD-L1 Drug Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global PD-1 and PD-L1 Drug Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Liver Cancer
Figure 27. Esophageal Cancer
Figure 28. Nasal Cancer
Figure 29. Stomach Cancer
Figure 30. Other
Figure 31. By Application, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global PD-1 and PD-L1 Drug Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)
Figure 34. By Application, Global PD-1 and PD-L1 Drug Sales Quantity Market Share, 2018-2029
Figure 35. By Application, Global PD-1 and PD-L1 Drug Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 36. By Region, Global PD-1 and PD-L1 Drug Consumption Value Market Share, 2018-2029
Figure 37. By Region, Global PD-1 and PD-L1 Drug Sales Quantity Market Share, 2018-2029
Figure 38. North America PD-1 and PD-L1 Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, North America PD-1 and PD-L1 Drug Consumption Value Market Share, 2022
Figure 40. Europe PD-1 and PD-L1 Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, Europe PD-1 and PD-L1 Drug Consumption Value Market Share, 2022
Figure 42. Asia Pacific PD-1 and PD-L1 Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country/Region, Asia Pacific PD-1 and PD-L1 Drug Consumption Value Market Share, 2022
Figure 44. South America PD-1 and PD-L1 Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, South America PD-1 and PD-L1 Drug Consumption Value Market Share, 2022
Figure 46. Middle East & Africa PD-1 and PD-L1 Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. U.S. PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, U.S. PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, Europe PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 53. China PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, China PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, Japan PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, South Korea PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, South Korea PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 62. Southeast Asia PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, Southeast Asia PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, Southeast Asia PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 65. India PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, India PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, India PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 68. Middle East & Africa PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)
Figure 69. By Type, Middle East & Africa PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, Middle East & Africa PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up and Top-down Approaches
Figure 74. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|